Tenon Medical, Inc. (TNON) Stock Price & Analysis

Tenon Medical, Inc. (TNON) rose 0.00% to USD 0.19 as of July 25, 2026 at 03:05 UTC, according to Nexqual real-time market data.

TNON last closed at USD 0.19; the session ranged USD 0.18–0.2 on volume of 199,767 shares. Market capitalization is —, with a 52-week range of USD 0.18–2.48 (NCM). Source: Nexqual, July 25, 2026 at 03:05 UTC.

Key Statistics (as of July 25, 2026 at 03:05 UTC)

Technical Analysis (TNON)

Nexqual's technical model rates TNON "SELL" based on 1 bullish and 5 bearish signals across 125 daily candles, as of July 25, 2026 at 03:05 UTC.

From Tenon Medical, Inc.'s Latest SEC 10-K Filing (filed 2026-03-27)

Key Strengths & Strategy (as disclosed to the SEC)

• We have developed The Catamaran ® ™ SI Joint Fusion System ("The Catamaran System") that offers a novel, less invasive approach to the SI Joint using a single, robust, titanium implant for treatment of the most common types of SI Joint disorders that cause lower back pain.
• Food and Drug Administration ("FDA") clearance in 2018 for The Catamaran System and are currently focused on the US market.
• The Catamaran System is a singular implant designed with several proprietary components which allow for it to be explicitly formatted to address the SI Joint with a single, less invasive approach and implant.
• We believe The Catamaran System will address a large market opportunity with a superior product and is distinct from other competitive offerings in the following ways:                     The Catamaran System is a singular implant designed with several proprietary components which allow for it to be explicitly formatted to transfix the SI Joint with a single approach and implant.

Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.

Peers & Related Stocks

Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 03:05 UTC. This page is informational and not investment advice.